4/A: Horton Capital Amends KORU Medical Ownership Filing

Horton Capital Partners Fund, LP reports an amendment to its beneficial ownership of KORU Medical Systems, Inc. following a director compensation grant.

Summary

• This filing is an amendment to a previously submitted Form 4 regarding the beneficial ownership of KORU Medical Systems, Inc. (KRMD) by Joseph M. Manko, Jr. and associated entities.
• The amendment clarifies the acquisition of 3,472 shares of common stock granted to Horton Capital Partners Fund, LP on March 31, 2026, as compensation for Mr. Manko's service as a director.
• The filing corrects the total beneficial ownership count to include a transaction previously reported on February 13, 2026.
• The reporting group maintains a significant position of 5,065,970 shares held indirectly through Horton Capital Partners Fund, LP.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing intended to correct reporting errors and disclose standard director compensation.

Positives

• Director compensation via equity aligns the interests of the reporting person with those of other shareholders.
• The amendment provides transparency and corrects historical reporting errors regarding total share counts.

Negatives

• The need for an amendment indicates a prior administrative error in the reporting of beneficial ownership.

Risks

• Regulatory scrutiny regarding the accuracy of Section 16 filings.
• Potential for future administrative or reporting discrepancies.

Future Outlook

No specific forward-looking guidance regarding company operations or financial performance is provided in this ownership disclosure.

Management Comments

• The reporting persons disclaim beneficial ownership of the securities except to the extent of their pecuniary interest.
• The filing is not an admission that the reporting persons are the beneficial owners for Section 16 purposes.

Industry Context

StockSavvy.ai notes that institutional investors and directors frequently receive equity-based compensation in the medical device sector to ensure long-term alignment with corporate performance goals.

Comparison to Industry Standards

• Equity-based director compensation is a standard practice for small-cap medical technology companies like KORU Medical Systems.
• The reporting structure involving investment advisory firms and general partners is consistent with standard institutional investment disclosure requirements.

Related Party Transactions

• The filing discloses the relationship between Joseph M. Manko, Jr., Horton Capital Management, LLC, and Horton Capital Partners Fund, LP regarding the management and voting power of KRMD shares.

Stakeholder Impact

• Shareholders are provided with updated and accurate information regarding the significant ownership stake held by the Horton Capital group.

Next Steps

• Continued monitoring of Section 16 filings for any further changes in beneficial ownership by the Horton Capital group.

Key Dates

Keywords

KRMD, KORU Medical Systems, Beneficial Ownership, Form 4, Horton Capital, Director Compensation, SEC Filing